Personal information

Verified email domains

Retinal Gene Therapy

Biography

Peter M.J. Quinn is a British molecular geneticist, stem cell biologist, and genome engineer. Dr. Quinn is an Assistant Professor of Ophthalmology and Principal Investigator of the PrimeSight Lab at the University of Pennsylvania. The labs focus is to provide clinically translatable impact using iPSC-derived ophthalmic organoid-based approaches for the understanding and treatment of retinal degenerative diseases. The PrimeSight team is currently developing gene-specific and gene-agnostic therapeutics for the amelioration of the phenotypic, histopathological, and molecular changes in several inherited retinal disease iPSC-derived retinal organoid models. Further, they are establishing projects on autosomal dominant optic atrophy and genetic glaucoma.

Please donate to our research: https://giving.apps.upenn.edu/fund?program=MED&fund=605907

Activities

Employment (4)

University of Pennsylvania: Philadelphia, US

2024-08-01 to present | Assistant Professor of Ophthalmology (Ophthalmology)
Employment
Source: Self-asserted source
Peter M.J. Quinn

Columbia University: New York, New York, US

2021-11-01 to 2024-07-31 | Associate Research Scientist (Ophthalmology)
Employment
Source: Self-asserted source
Peter M.J. Quinn

Columbia Univeristy: New York, US

2019-08-01 to 2021-10-31 | Postdoctoral Fellow (Ophthalmology)
Employment
Source: Self-asserted source
Peter M.J. Quinn

Epistem: Manchester, GB

2007 to 2010 | Research Associate (Novel Therapies)
Employment
Source: Self-asserted source
Peter M.J. Quinn

Education and qualifications (3)

University of Manchester: Manchester, Manchester, GB

BSc (Hons), Biological Science 2008
Education
Source: Self-asserted source
Peter M.J. Quinn

Leiden University Medical Center: Leiden, NL

PhD 2019 (Opthamology)
Education
Source: Self-asserted source
Peter M.J. Quinn

Brunel University: Uxbridge, Middlesex, GB

MSc, Molecular Medicine and Cancer Research 2011
Education
Source: Self-asserted source
Peter M.J. Quinn

Peer review (2 reviews for 1 publication/grant)

Review activity for Molecular therapy (2)